Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Harnessing open innovation

    Nature Reviews Drug Discovery volume 8, pages 344–345 (2009)Cite this article

    Could coupling the recent explosion in large-scale biological data to novel models for pre-competitive collaboration help tackle the challenges of innovative drug development? Bethan Hughes investigates.

    On 1 July 2009, the incubation phase of a new open-access platform called Sage (http://sagebase.org) should begin. With logistical support and data from Merck and seed money from private sources, Eric Schadt and co-founder Stephen Friend — who are both moving from senior positions at Merck — aim to build complex, predictive models of disease. “The idea is to integrate large-scale biological information into models and then enable other scientists to leverage that information in an open-access way [freely available with no intellectual property (IP) restrictions],” says Schadt.

    This is a preview of subscription content, access via your institution

    Access options

    Rent or buy this article

    Get just this article for as long as you need it

    $39.95

    Learn more

    Prices may be subject to local taxes which are calculated during checkout

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Harnessing open innovation. Nat Rev Drug Discov 8, 344–345 (2009). https://doi.org/10.1038/nrd2891

    Download citation

    • Issue Date:

    • DOI: https://doi.org/10.1038/nrd2891

    This article is cited by

    Search

    Advanced search

    Quick links

    Nature Briefing

    Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

    Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing